Discover how the acellular collagen matrix mucoderm® from botiss biomaterials provides a safe and effective alternative to autologous soft-tissue grafts. Derived from porcine dermis, mucoderm® undergoes a multi-step purification process that removes all non-collagenous components while preserving its native 3D collagen structure (types I and III). This unique matrix supports rapid vascularization and is fully remodeled into the patient’s own connective tissue within 6–9 months.

mucoderm® is indicated for soft-tissue augmentation around implants, widening keratinized gingiva, and root-coverage procedures—especially when harvesting autologous tissue is limited or undesired. For full specifications, hydration protocols, and a wide range of clinical cases and surgical applications, visit https://botiss.com/product/mucoderm/.